Clinical Trial Update: Single Dose Escalation Study of PF-05190457 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 single-dose escalation study of PF-05190457 in healthy volunteers, reporting safety and pharmacokinetic data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-05190457

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type II | Phase 1 | Status: COMPLETED